Á lódáil...
Treating cancer when pRb and p53 cannot be reactivated
Activation of oncoproteins and inactivation of tumor suppressors induces tumorigenesis. When these events happen upstream of pRb and p53, cancer therapies may initially succeed and then fail when pRb and p53 are activated and then re-inactivated. Therapies might succeed if they remain effective when...
Na minha lista:
| Foilsithe in: | Mol Cell Oncol |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Taylor & Francis
2015
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905341/ https://ncbi.nlm.nih.gov/pubmed/27308498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1004954 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|